Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Recruiting 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 13Rectal Neoplasms 5Neoplasm Metastasis 4Cholangiocarcinoma 4Stomach Neoplasms 3Colonic Neoplasms 3Carcinoma, Hepatocellular 3Biliary Tract Neoplasms 3Adenocarcinoma Of Esophagus 3Ovarian Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Recurrence 1Pathologic Complete Response 1Lung Neoplasms 1Endometrial Neoplasms 1Disease Progression 1Central Nervous System Neoplasms 1Carcinoma, Basal Cell 1Breast Neoplasms 1Bile Duct Neoplasms 1Advanced Rectal Cancer 1Adenocarcinoma of the Lower Rectum 1Adenocarcinoma 1

Interventions

Oxaliplatin 25Fluorouracil 20Capecitabine 17Nivolumab 16pembrolizumab 15Leucovorin 13Trastuzumab 9fludarabine 8S 1 (combination) 8Paclitaxel 8Drug Therapy 8Docetaxel 8Cyclophosphamide 8Specimen Handling 7trastuzumab deruxtecan 6Cisplatin 6Magnetic Resonance Spectroscopy 5Biopsy 5Bevacizumab 5zolbetuximab 4Irinotecan 4zimberelimab 3sintilimab 3fludarabine phosphate 3atezolizumab 3aldesleukin 3XELOX 3Surgical Procedures, Operative 3Ramucirumab 3Radiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Stomach Neoplasms × Folfox protocol × 90 days × Clear all
NCT07221149 2026-06-04

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Bristol-Myers Squibb

Phase 2/3 Recruiting
690 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT05702229 2026-05-14

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

AstraZeneca

Phase 2 Recruiting
163 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06346197 2026-04-21

CIME

Centre Leon Berard

Phase 3 Recruiting
132 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡